Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Ingredient Pimecrolimus, Atc D11ah02, For The Period 01.05.2025 - 30.04.2027 2025-09-13
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Ingredient Dupilumab, Atc D11ah05, For The Period 01.05.2025 - 30.04.2027 2025-09-13
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Code Book V 2025-09-13
Germany House Drug Discount Agreements For The Active Ingredient Mepolizumab, Atc 2025-09-13
Germany Open House Pharmaceutical Discounts On The Active Ingredient Omalizumab, Atc R03dx05, 67304 Eisenberg Rhineland-palatinate 2025-09-13
Germany Open House Pharmaceutical Department Treaties To The Active Ingredient Amifampridine, Atc N07xx05, 67304 Eisenberg Rhineland-palatinate 2025-09-13
Germany Open House Pharmaceutical Department Treaties To The Active Ingredient Aripiprazole, As A Depot Injectionsus Pension, Atc N05ax12, 67304 Eisenberg Rhineland-palatinate 2025-09-13
Germany Open House Pharmaceutical Discounts On The Active Ingredient Urapidil, Atc C02ca06, 67304 Eisenberg Rhineland-palatinate 2025-09-13
Germany Open House Pharmaceutical Discounts On The Active Ingredient Secukinumab, Atc L04ac10, 67304 Eisenberg Rhineland-palatinate 2025-09-13
Germany Open House Pharmaceutical Discounts On The Active Ingredient Certolizumab Pegol, Atc L04ab05, 67304 Eisenberg Rhineland-palatinate 2025-09-13
Whats app